DOUGLAS MAYO: Open Payments
NPI 1942674254 · WELDON SPRING, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,060 in 61 payments from 21 companies in 2025. Trend: 2023 $472 · 2024 $498 · 2025 $1,060
Food & beverage: $1,060
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $328 |
| Vanda Pharmaceuticals Inc. | 5 | $127 |
| Novo Nordisk Inc | 6 | $112 |
| Dexcom, Inc. | 2 | $54 |
| PFIZER INC. | 3 | $53 |
| Lilly USA, LLC | 3 | $48 |
| Cranial Technologies, Inc | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Amgen Inc. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
Products named: VRAYLAR, FANAPT, Wegovy, QULIPTA, Dexcom G6 Transmitter, Doc Band, CAPLYTA, UBRELVY.
Industry payments across MO — which companies pay providers there.
